Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Cognate BioServices
company
About
Cognate provides full development and cGMP manufacturing services to companies engaged in the development of cell-based products.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series Unknown
- Industries
- Biotechnology,Health Care,Manufacturing
- Founded date
- Jan 1, 2002
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
—
Cognate BioServices has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Jan 22, 2020 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 22, 2020 | Series B | — | 1 | — | — | Detail |
| Feb 20, 2018 | Series Unknown | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Cognate BioServices is funded by 1 investors.
Medivate Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Medivate Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
